AMGEN Inc (NASDAQ: AMGN) is 19.78% higher on its value in year-to-date trading and has touched a low of $253.30 and a high of $346.85 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The AMGN stock was last observed hovering at around $310.78 in the last trading session, with the day’s gains setting it 1.41%.
Currently trading at $312.19, the stock is 3.73% and 10.73% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.81 million and changing 0.45% at the moment leaves the stock 2.02% off its SMA200. AMGN registered 14.01% gain for a year compared to 6-month loss of -5.69%.
The stock witnessed a 9.38% gain in the last 1 month and extending the period to 3 months gives it a 11.47%, and is -1.09% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.22% over the week and 2.43% over the month.
AMGEN Inc (AMGN) has around 28000 employees, a market worth around $167.71B and $33.23B in sales. Current P/E ratio is 41.37 and Fwd P/E is 14.42. Profit margin for the company is 12.31%. Distance from 52-week low is 23.25% and -9.99% from its 52-week high. The company has generated returns on investments over the last 12 months (6.48%).
with sales reaching $8.05B over the same period.The EPS is expected to grow by 4.19% this year, but quarterly earnings will post 5.29% year-over-year. Quarterly sales are estimated to grow 8.14% in year-over-year returns.
AMGEN Inc (AMGN) Top Institutional Holders
The shares outstanding are 536.90M, and float is at 536.16M with Short Float at 3.00%.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 51.87 million shares valued at $16.21 billion. The investor’s holdings represent 9.6779% of the AMGN Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 46.04 million shares valued at $$14.39 billion to account for 8.5901 of the shares outstanding. The other top investors are STATE STREET CORP which holds 28.97 million shares representing 5.3951% and valued at over $9.05 billion, while PRIMECAP MANAGEMENT CO/CA/ holds 2.6903 of the shares totaling 14.45 million with a market value of $4.51 billion.
AMGEN Inc (AMGN) Insider Activity
A total of 0 insider transactions have happened at AMGEN Inc (AMGN) in the last six months, with sales accounting for 0 and purchases happening 0 times. The most recent transaction is an insider sale by Santos Esteban,the company’sEVP, Operations. SEC filings show that Santos Esteban sold 8,711 shares of the company’s common stock on Feb 19 ’25 at a price of $292.84 per share for a total of $2.55 million. Following the sale, the insider now owns 71546.0 shares.
AMGEN Inc disclosed in a document filed with the SEC on Feb 21 ’25 that REESE DAVID M (EVP & Chief Technology Officer) sold a total of 25,225 shares of the company’s common stock. The trade occurred on Feb 21 ’25 and was made at $304.44 per share for $7.68 million. Following the transaction, the insider now directly holds 36922.0 shares of the AMGN stock.
Still, SEC filings show that on Feb 19 ’25, REESE DAVID M (EVP & Chief Technology Officer) disposed off 8,711 shares at an average price of $293.22 for $2.55 million. The insider now directly holds 62,147 shares of AMGEN Inc (AMGN).
AMGEN Inc (AMGN): Who are the competitors?
The company’s main competitors (and peers) include Johnson & Johnson (JNJ) that is trading 3.82% up over the past 12 months. Pfizer Inc. (PFE) that is -5.30% lower over the same period.
